SUBSCRIBE
SUBSCRIBE
News   Drug Development

Phytopharm PLC Shares Soar on Parkinson’s Drug Promise; Stock Up 339.64% at Market Close

October 14, 2009 | 
1 min read
Bookmark and Share

Reuters -- British biotech minnow Phytopharm reported promising early test results with its Parkinson's disease drug Cogane on Wednesday, propelling the stock as much as 350 percent higher.
Preclinical
MORE ON THIS TOPIC
Stagflation, economic slow down or recession while inflation high up, GDP growth decrease causing by unemployment concept, fearful businessman riding fall down economic graph with inflation high up.
Cardiovascular disease
AstraZeneca, Ionis slip as ATTR-CM drug fails Phase 3
July 9, 2026
 · 
3 min read
 · 
Tristan Manalac
Podcast
Vertex carries M&A uptick into H2, IPOs and VC raises also grow, FDA on pace despite turmoil
July 8, 2026
 · 
1 min read
 · 
Jef Akst
3d render of the pole vault crossbar on blue sky background
Obesity
Hengrui, Kailera’s oral GLP-1 clears late-stage bar in China but US results still pending
July 7, 2026
 · 
4 min read
 · 
Gabrielle Masson
Communication by thoughts
Psychedelics
Compass’ psilocybin depression drug works for the long haul
July 7, 2026
 · 
2 min read
 · 
Annalee Armstrong